NO963427L - 11-(substituert fenyl)-östra-4,9-dien-derivater - Google Patents

11-(substituert fenyl)-östra-4,9-dien-derivater

Info

Publication number: NO963427L
Authority: NO; Norway
Prior art keywords: ostra; substituted phenyl; diene derivatives; diene; derivatives
Prior art date: 1995-08-17

Application number

NO963427A

Other languages

English (en)

Other versions

NO963427D0 (no

NO306257B1 (no

Inventor

Ronald Gebhard

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-17

Filing date

1996-08-16

Publication date

1997-02-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8220570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO963427(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-08-16 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

1996-08-16 Publication of NO963427D0 publication Critical patent/NO963427D0/no

1997-02-18 Publication of NO963427L publication Critical patent/NO963427L/no

1999-10-11 Publication of NO306257B1 publication Critical patent/NO306257B1/no

Links

125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0016—Oximes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Addiction (AREA)
Ophthalmology & Optometry (AREA)
Anesthesiology (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO963427A 1995-08-17 1996-08-16 11-(substituert fenyl)-östra-4,9-dien-derivater, farmasöytisk preparat og anvendelse derav NO306257B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP95202229		1995-08-17

Publications (3)

Publication Number	Publication Date
NO963427D0 NO963427D0 (no)	1996-08-16
NO963427L true NO963427L (no)	1997-02-18
NO306257B1 NO306257B1 (no)	1999-10-11

Family

ID=8220570

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO963427A NO306257B1 (no)	1995-08-17	1996-08-16	11-(substituert fenyl)-östra-4,9-dien-derivater, farmasöytisk preparat og anvendelse derav

Country Status (25)

Country	Link
US (1)	US6011025A (no)
EP (1)	EP0763541B1 (no)
JP (1)	JP3977462B2 (no)
KR (1)	KR100445376B1 (no)
CN (1)	CN1129602C (no)
AR (1)	AR003982A1 (no)
AT (1)	ATE182596T1 (no)
AU (1)	AU711369B2 (no)
BR (1)	BR9603429A (no)
CA (1)	CA2182771C (no)
CZ (1)	CZ287740B6 (no)
DE (1)	DE69603425T2 (no)
DK (1)	DK0763541T3 (no)
ES (1)	ES2137625T3 (no)
GR (1)	GR3031116T3 (no)
HU (1)	HU229023B1 (no)
IL (1)	IL118974A (no)
NO (1)	NO306257B1 (no)
NZ (1)	NZ299181A (no)
PL (1)	PL183468B1 (no)
RU (1)	RU2135514C1 (no)
SG (1)	SG52834A1 (no)
TR (1)	TR199600664A2 (no)
TW (1)	TW464654B (no)
ZA (1)	ZA966555B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0903146A1 (en) *	1997-09-23	1999-03-24	Applied Research Systems ARS Holdings N.V.	21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
EP1726307A3 (en) *	1997-10-06	2007-04-04	The Board Of Trustees Of The Leland Stanford Junior University	Methods for treating psychosis associated with glucocorticoid related dysfunction
AU747956B2 (en) *	1997-10-06	2002-05-30	Board Of Trustees Of The Leland Stanford Junior University	Methods for treating psychosis associated with glucocorticoid related dysfunction
CA2328411C (en)	1998-05-15	2008-12-16	Alan F. Schatzberg	Glucocorticoid receptor antagonists for the treatment of dementia
ES2204613T3 (es) *	1999-04-06	2004-05-01	Akzo Nobel N.V.	Androgenos 7-alfa alquilo oralmente activos.
DE60233111D1 (de) *	2001-02-14	2009-09-10	Karobio Ab	Glucocorticoid-rezeptoren-modulatoren
EP1285927A3 (de)	2001-08-16	2005-06-29	Schering Aktiengesellschaft	Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems
CN100531738C (zh) *	2001-10-26	2009-08-26	欧加农股份有限公司	(11β,17β)-11-(1,3-苯并间二氧杂环戊烯-5-基)-17-羟基-17-(1-丙炔基)雌-4,9-二烯-3-酮在治疗重性抑郁症中的应用
US8193172B2 (en)	2001-11-23	2012-06-05	Pop Test Cortisol Llc	Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists
CA2504751C (en) *	2002-11-05	2013-02-05	Corcept Therapeutics, Inc.	Methods for treating gastroesophageal reflux disease
AU2004208842B2 (en) *	2003-02-04	2009-05-28	Corcept Therapeutics, Inc.	Antiglucocorticoids for the treatment of postpartum psychosis
TW200820977A (en)	2006-08-08	2008-05-16	Organon Nv	Use of glucocorticoid receptor antagonists for treatment of infectious conditions
US8658128B2 (en) *	2011-02-03	2014-02-25	Pop Test Cortisol Llc	System and method for diagnosis and treatment
WO2012129305A1 (en) *	2011-03-23	2012-09-27	Pop Test Cortisol Llc	Combination therapy
EP2712317B1 (en)	2011-03-31	2018-09-19	Pop Test Oncology LLC	Prevention of infection
WO2012145258A1 (en) *	2011-04-18	2012-10-26	Pop Test Cortisol Llc	Hair loss treatment
US8986677B2 (en)	2012-07-30	2015-03-24	Pop Test Cortisol Llc	Therapeutic compositions and methods
EP3151906B1 (en)	2014-06-03	2019-12-11	Pop Test Abuse Deterrent Technology LLC	Drug device configured for wireless communication
JP6821582B2 (ja) *	2015-03-02	2021-01-27	コーセプトセラピューティクス，インコーポレイテッド	Ａｃｔｈ分泌腫瘍を処置するための糖質コルチコイドレセプターアンタゴニストおよびソマトスタチンアナログの使用
EP3273983B1 (en)	2015-03-23	2021-05-05	Evestra, Inc.	Novel cytotoxic agents that preferentially target leukemia inhibitory factor (lif) for the treatment of malignancies and as new contraceptive agents
JP6754533B2 (ja)	2015-03-30	2020-09-16	コーセプトセラピューティクス，インコーポレイテッド	副腎機能不全を処置するための糖質コルチコイドと組み合わせた糖質コルチコイドレセプターアンタゴニストの使用
US9598459B2 (en) *	2015-08-03	2017-03-21	Pop Test Oncology Llc	Pharmaceutical compositions and methods
EP3400233B1 (en) *	2015-08-03	2025-10-22	Pop Test Oncology LLC	Pharmaceutical compositions and methods
MX383318B (es)	2015-08-13	2025-03-13	Corcept Therapeutics Inc	Metodo para diagnosticar de manera diferencial el sindrome de cushing dependiente de la corticotropina.
JP6906525B2 (ja) *	2015-12-23	2021-07-21	オリックファーマシューティカルズ，インク．	グルココルチコイド受容体の阻害剤
WO2017112909A1 (en) *	2015-12-23	2017-06-29	Oric Pharmaceuticals, Inc.	Inhibitors of glucocorticoid receptor
US11110103B2 (en)	2015-12-23	2021-09-07	Oric Pharmaceuticals, Inc.	Inhibitors of glucocorticoid receptor
JP6765443B2 (ja)	2016-01-19	2020-10-07	コーセプトセラピューティクス，インコーポレイテッド	異所性クッシング症候群の鑑別診断
PT3523315T (pt) *	2016-10-07	2021-04-29	Oric Pharmaceuticals Inc	Inibidor de recetor de glucocorticoide
WO2018236749A2 (en)	2017-06-20	2018-12-27	Corcept Therapeutics, Inc.	Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
AU2020239920A1 (en)	2019-03-18	2021-11-04	Arnold L. Newman	Method of improving insulin sensitivity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA8231B (en) *	1981-01-09	1982-11-24	Roussel Uclaf	New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) *	1982-03-01	1986-02-14	Roussel Uclaf	Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
US4780461A (en) *	1983-06-15	1988-10-25	Schering Aktiengesellschaft	13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3625315A1 (de) *	1986-07-25	1988-01-28	Schering Ag	11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
IE60780B1 (en) *	1987-01-23	1994-08-10	Akzo Nv	New 11-aryl steroid derivatives
DE3708942A1 (de) *	1987-03-18	1988-09-29	Schering Ag	19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3717169A1 (de) *	1987-05-19	1988-12-01	Schering Ag	19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3723788A1 (de) *	1987-07-16	1989-01-26	Schering Ag	11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3822770A1 (de) *	1988-07-01	1990-01-04	Schering Ag	13-alkyl-11ss-phenylgonane
DK0411733T3 (da) *	1989-08-04	1999-06-28	Schering Ag	11-beta-aryl-gona-4,9-dien-3-oner
WO1995004536A1 (en) *	1993-08-04	1995-02-16	Akzo Nobel N.V.	Antiglucocorticoid steroids for the treatment of anxiety disorders
DK0683172T3 (da) *	1994-05-19	1998-03-30	Akzo Nobel Nv	11,21-bisphenyl-19-norpregnanderivater

1996
- 1996-07-29 IL IL11897496A patent/IL118974A/en not_active IP Right Cessation
- 1996-08-01 ZA ZA9606555A patent/ZA966555B/xx unknown
- 1996-08-06 CA CA002182771A patent/CA2182771C/en not_active Expired - Fee Related
- 1996-08-12 JP JP21282496A patent/JP3977462B2/ja not_active Expired - Fee Related
- 1996-08-13 AT AT96202273T patent/ATE182596T1/de active
- 1996-08-13 DE DE69603425T patent/DE69603425T2/de not_active Expired - Lifetime
- 1996-08-13 EP EP96202273A patent/EP0763541B1/en not_active Expired - Lifetime
- 1996-08-13 DK DK96202273T patent/DK0763541T3/da active
- 1996-08-13 CZ CZ19962386A patent/CZ287740B6/cs not_active IP Right Cessation
- 1996-08-13 ES ES96202273T patent/ES2137625T3/es not_active Expired - Lifetime
- 1996-08-14 BR BR9603429A patent/BR9603429A/pt not_active IP Right Cessation
- 1996-08-14 KR KR1019960033671A patent/KR100445376B1/ko not_active Expired - Fee Related
- 1996-08-14 SG SG1996010458A patent/SG52834A1/en unknown
- 1996-08-15 TR TR96/00664A patent/TR199600664A2/xx unknown
- 1996-08-15 NZ NZ299181A patent/NZ299181A/en not_active IP Right Cessation
- 1996-08-16 AR ARP960104036A patent/AR003982A1/es unknown
- 1996-08-16 PL PL96315733A patent/PL183468B1/pl not_active IP Right Cessation
- 1996-08-16 NO NO963427A patent/NO306257B1/no not_active IP Right Cessation
- 1996-08-16 AU AU62119/96A patent/AU711369B2/en not_active Ceased
- 1996-08-16 CN CN96111830A patent/CN1129602C/zh not_active Expired - Fee Related
- 1996-08-16 HU HU9602269A patent/HU229023B1/hu not_active IP Right Cessation
- 1996-08-16 RU RU96115774/04A patent/RU2135514C1/ru not_active IP Right Cessation
- 1996-08-22 TW TW085110266A patent/TW464654B/zh not_active IP Right Cessation
1997
- 1997-09-22 US US08/935,360 patent/US6011025A/en not_active Expired - Lifetime
1999
- 1999-08-31 GR GR990402198T patent/GR3031116T3/el unknown

Also Published As

Publication number	Publication date
PL183468B1 (pl)	2002-06-28
DK0763541T3 (da)	2000-02-28
HUP9602269A3 (en)	1997-12-29
SG52834A1 (en)	1998-09-28
AU711369B2 (en)	1999-10-14
CZ287740B6 (en)	2001-01-17
JP3977462B2 (ja)	2007-09-19
CA2182771A1 (en)	1997-02-18
HU9602269D0 (en)	1996-10-28
ATE182596T1 (de)	1999-08-15
US6011025A (en)	2000-01-04
CN1147520A (zh)	1997-04-16
JPH09104696A (ja)	1997-04-22
MX9603476A (es)	1997-07-31
NO963427D0 (no)	1996-08-16
CZ238696A3 (en)	1997-05-14
ZA966555B (en)	1997-02-19
IL118974A (en)	2001-09-13
TR199600664A2 (tr)	1997-03-21
RU2135514C1 (ru)	1999-08-27
EP0763541B1 (en)	1999-07-28
DE69603425T2 (de)	2000-01-20
NZ299181A (en)	1997-09-22
ES2137625T3 (es)	1999-12-16
NO306257B1 (no)	1999-10-11
HUP9602269A2 (en)	1997-04-28
EP0763541A1 (en)	1997-03-19
IL118974A0 (en)	1996-10-31
TW464654B (en)	2001-11-21
KR100445376B1 (ko)	2004-11-08
AR003982A1 (es)	1998-09-30
KR970010784A (ko)	1997-03-27
HK1002010A1 (en)	1998-07-24
HU229023B1 (en)	2013-07-29
GR3031116T3 (en)	1999-12-31
CA2182771C (en)	2007-04-24
CN1129602C (zh)	2003-12-03
PL315733A1 (en)	1997-03-03
AU6211996A (en)	1997-02-20
BR9603429A (pt)	1998-05-12
DE69603425D1 (de)	1999-09-02

Legal Events

Date	Code	Title	Description
2014-03-24	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO963427D0 (no)	1996-08-16	11-(substituerte fenyl)-östra-4,9-dien-derivater
NL300214I1 (nl)	2006-03-01	Chinazolinederivaten.
DE69736711D1 (de)	2006-11-02	Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da)	2004-08-09	Substituerede 6,6-heterobicykliske derivater
DK1000048T3 (da)	2003-03-03	Substituerede 1,2,3,4-tetrahydronapthalenderivater
FI950715A0 (fi)	1995-02-17	Ytmikromekanisk, symmetrisk tryckskillnadsgivare
TR199600883A2 (tr)	1997-05-21	Pürin-6-on türevleri.
NO993459L (no)	1999-09-07	16-hydroksy-11-(substituerte fenyl)-estra-4,9-dien-derivater
DE69718771D1 (de)	2003-03-06	Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DK0922050T3 (da)	2003-11-24	3-Descladinose-2,3-anhydroerythromycin-derivater
TR199600715A2 (tr)	1997-03-21	Kefalosforin türevleri.
DE59607332D1 (de)	2001-08-30	Antineurodegenerativ wirksame 10-Aminoaliphatyl-dibenz- b,f oxepine
ATE241599T1 (de)	2003-06-15	25-hydroxy-16-ene-26,27-bishome-cholecalcerifer l derivate
TR199600064A2 (tr)	1996-08-21	4-amino-benzoilguanidin-türevleri.
BR9507016A (pt)	1997-09-09	Derivados de oxima
FI970833L (fi)	1997-02-27	Dihydro-2,3-bentsodiatsepiinijohdannaiset
TR28915A (tr)	1997-08-06	Naftokinon türevleri.
ES1032571Y (es)	1996-11-01	Gafa,
DE59508591D1 (de)	2000-08-24	2-arylcyclopentan-1,3-dion-derivate
FI952782A0 (fi)	1995-06-07	Braennare, i synnerhet foer foerbraenning av flytande braensle och en braensle-vattenblandning
FI954044A0 (fi)	1995-08-29	Foerfarande, anordning och bruk saerskilt foer avlaegnande av arsin ifraon vatten
FI954754A0 (fi)	1995-10-06	Anordning foer kvistning, kupning och klyvning av traed
BR1100649A (pt)	2003-10-07	Derivados de 10,11-metano dibenzo suberano
FI955780A0 (fi)	1995-12-01	Foerfarande, borrningsanordning och bruk foer borrning
FI950577A0 (fi)	1995-02-10	Installationsgolv, installationsfoerfarande och anvaendning